This ambitious research receives support from the:
- National Institute for Health Research
- Wellcome Trust
- Medical Research Council
We have recognition for our groundbreaking work. Newcastle, together with University College London, gained Medical Research Council centre status.
This allows us to focus on the translational aspects of neuromuscular research. It provides us with a group of clinicians and scientists of wide expertise and interests.
- standards of care
for genetic muscle disease. The neuromuscular group has received significant support from the European Union.
This is for organising a successful international collaboration. It develops and introduces novel treatments for neuromuscular disorders (TREAT NMD).
They work on different aspects of neurogenetic and neuro-ophthalmological disorders. They research on the mitochondrial encephalomyopathies.
Their research embraces a variety of other neurodegenerative diseases, affecting the:
- visual pathways
- peripheral nerves (cerebellar ataxias, optic neuropathies, spastic paraplegias and peripheral neuropathies)
This comprehensive service also provides patients access to specialised genetic investigations. This includes next-generation exome sequencing, with support from trained genetic counsellors.